Literature DB >> 9334325

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Y Zhu1, T Pe'ery, J Peng, Y Ramanathan, N Marshall, T Marshall, B Amendt, M B Mathews, D H Price.   

Abstract

P-TEFb is a key regulator of the process controlling the processivity of RNA polymerase II and possesses a kinase activity that can phosphorylate the carboxy-terminal domain of the largest subunit of RNA polymerase II. Here we report the cloning of the small subunit of Drosophila P-TEFb and the finding that it encodes a Cdc2-related protein kinase. Sequence comparison suggests that a protein with 72% identity, PITALRE, could be the human homolog of the Drosophila protein. Functional homology was suggested by transcriptional analysis of an RNA polymerase II promoter with HeLa nuclear extract depleted of PITALRE. Because the depleted extract lost the ability to produce long DRB-sensitive transcripts and this loss was reversed by the addition of purified Drosophila P-TEFb, we propose that PITALRE is a component of human P-TEFb. In addition, we found that PITALRE associated with the activation domain of HIV-1 Tat, indicating that P-TEFb is a Tat-associated kinase (TAK). An in vitro transcription assay demonstrates that the effect of Tat on transcription elongation requires P-TEFb and suggests that the enhancement of transcriptional processivity by Tat is attributable to enhanced function of P-TEFb on the HIV-1 LTR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334325      PMCID: PMC316609          DOI: 10.1101/gad.11.20.2622

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.

Authors:  N F Marshall; J Peng; Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 2.  Reversible phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  M E Dahmus
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

Review 3.  The RNA polymerase II general elongation factors.

Authors:  D Reines; J W Conaway; R C Conaway
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

4.  Purification of an RNA polymerase II transcript release factor from Drosophila.

Authors:  Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

5.  Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.

Authors:  P Veschambre; P Simard; P Jalinot
Journal:  J Mol Biol       Date:  1995-07-07       Impact factor: 5.469

6.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.

Authors:  X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product.

Authors:  H Tsuchiya; T Iseda; O Hino
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

8.  Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II.

Authors:  G Mavankal; S H Ignatius Ou; H Oliver; D Sigman; R B Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

9.  Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.

Authors:  R F Chun; K T Jeang
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

10.  Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.

Authors:  Q Zhou; P A Sharp
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

View more
  312 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.

Authors:  F Demarchi; M I Gutierrez; M Giacca
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 3.  Mechanism and regulation of transcriptional elongation by RNA polymerase II.

Authors:  D Reines; R C Conaway; J W Conaway
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

4.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication.

Authors:  O Flores; G Lee; J Kessler; M Miller; W Schlief; J Tomassini; D Hazuda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 6.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway.

Authors:  G Hautbergue; V Goguel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II.

Authors:  S M Carty; A C Goldstrohm; C Suñé; M A Garcia-Blanco; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

9.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

10.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.